When Not to Have Lens Replacement Surgery

REFRACTIVE LENS EXCHANGE – PATIENT SELECTION

This page is for patients considering refractive lens exchange (RLE) who want to understand which clinical situations make RLE inappropriate, and what the alternative options are.

Not Every Patient Benefits From RLE

Refractive lens exchange is a powerful procedure for the right patient, and a poor choice for the wrong one. Mr Hove declines approximately 12% of RLE enquiries each year on clinical grounds, redirecting those patients to ICL, laser, or optical correction. At Blue Fin Vision®, the patient selection framework is transparent, clinical, and explained at the first consultation. The following scenarios are the common reasons RLE is not offered.

Age Under 45 With a Clear Crystalline Lens

A 38-year-old with a clear crystalline lens and good accommodation has a natural optical system that is still functioning. RLE removes that lens and replaces it with an IOL that cannot accommodate, trading a working biological structure for an artificial one that provides a fixed optical correction. The risks of RLE in a young eye, including the small but real risk of retinal detachment in highly myopic eyes post-lensectomy, are not justified when ICL can correct the prescription without removing the natural lens.¹ For patients in this age group, ICL is the default recommendation.

High Myopia With Long Axial Length

Patients with high myopia (above -8D) have longer eyes and a measurable baseline risk of retinal detachment that is increased by any intraocular procedure, including RLE.⁴ Published series show the retinal detachment rate in high myopes undergoing RLE is approximately 2-8%, substantially higher than in emmetropic cataract patients. For this group, ICL, which does not breach the posterior capsule or increase axial traction, is preferred. A pre-operative retinal assessment, including peripheral dilated examination and OCT, is performed on every high myope considered for any intraocular procedure at Blue Fin Vision®.

Unrealistic Visual Expectations

RLE with trifocal IOL produces excellent spectacle independence in appropriately selected patients, but it does not produce 20/20 vision at all distances with zero optical compromise. Patients who cannot accept any level of halos, glare at night, or mild reduction in contrast sensitivity are not suitable for trifocal IOL.³ For this group, monofocal IOL with intentional monovision, or ICL if the patient is young enough, are better options. The consultation at Blue Fin Vision® includes a detailed review of what trifocal IOL does and does not deliver, so that patient expectations are aligned with achievable outcomes before surgery.

Significant Ocular Comorbidity

Patients with macular pathology (age-related macular degeneration, diabetic maculopathy, epiretinal membrane), significant glaucoma, or corneal disease may not achieve the visual outcome from RLE that a healthy eye would produce.² RLE is not declined on the basis of comorbidity alone, but the expected outcome is revised, and in some cases the procedure is deferred or replaced with monofocal IOL implantation rather than trifocal. The OCT macular scan performed at every RLE consultation identifies these conditions before surgery.

Active Dry Eye or Ocular Surface Disease

Any intraocular procedure in the presence of active ocular surface disease produces a worse refractive outcome, because the biometric measurements used to calculate IOL power depend on a stable tear film and regular corneal surface.⁵ Surface disease is treated first. Surgery is deferred until the surface is optimised. This is a temporary deferral, not a permanent contraindication.

Patients Who Have Not Understood the Irreversibility

RLE is irreversible. Unlike ICL, where the implant can be removed and the eye returns to its pre-procedure baseline, RLE permanently replaces the natural lens. A patient who has not internalised this distinction at the consultation is not ready for the procedure. The consultation at Blue Fin Vision® is paced to allow the patient to reflect, and a second consultation is offered if needed. The surgical decision is made at the patient’s pace, not the clinic’s.

Clinical Perspective

At Blue Fin Vision®, approximately 12% of RLE enquiries each year are redirected to an alternative procedure or deferred on the grounds above. This is not a restrictive practice, it is honest clinical selection. The patient who is told that RLE is not appropriate for their current clinical picture is given the clinical reasoning in full and a clear alternative pathway. In many cases, the alternative is ICL; in some, the patient is better served by updated spectacles or contact lenses until biological circumstances change.

Clinical Takeaway

RLE is not appropriate for every patient considering refractive surgery. Age under 45 with a clear lens, high myopia with long axial length, unrealistic trifocal expectations, significant ocular comorbidity, active surface disease, and insufficient understanding of irreversibility are the common reasons RLE is declined or deferred. Approximately 12% of RLE enquiries at Blue Fin Vision® are redirected annually. The correct response to a patient who is not suited for RLE is a better recommendation, not a modified pitch. If you are considering RLE and want an honest clinical assessment of whether it is the right procedure for you, book a consultation with Mr Hove.

References

1. Alio JL, Grzybowski A, El Aswad A, Romaniuk D. Refractive lens exchange. Surv Ophthalmol. 2014;59(6):579-98.
2. Rosen E, Alio JL, Dick HB, Dell S, Slade S. Efficacy and safety of multifocal intraocular lenses following cataract and refractive lens exchange: meta-analysis of peer-reviewed publications. J Cataract Refract Surg. 2016;42(2):310-28.
3. Wilkins MR, Allan BD, Rubin GS. Randomised trial of multifocal intraocular lenses versus monovision after bilateral cataract surgery. Ophthalmology. 2013;120(12):2449-55.
4. Colin J, Robinet A, Cochener B. Retinal detachment after clear lens extraction for high myopia: seven-year follow-up. Ophthalmology. 1999;106(12):2281-4.
5. Lundstrom M, Dickman M, Henry Y, Manning S, Rosen P, Tassignon MJ, et al. Differences between planned and achieved refractive outcomes after cataract surgery as registered in the European Registry of Quality Outcomes for Cataract and Refractive Surgery. J Cataract Refract Surg. 2020;46(1):89-95.